248
Participants
Start Date
December 27, 2017
Primary Completion Date
December 21, 2023
Study Completion Date
December 21, 2023
Coherex WaveCrest® Left Atrial Appendage Occlusion System
Percutaneous left atrial appendage closure
Watchman® LAA Closure Device
Percutaeous left atrial appendage closure
St. Vincent's Hospital, Sydney
New York University- NYU Langone Cardiac, New York
New York University, New York
Icahn School of Medicine at Mount Sinai, New York
Northwell Health, Bay Shore
UPMC Pinnacle Health Cardiovascular Institute, Harrisburg
Medstar Heart and Vascular Institute - Washington Hospital Center, Washington D.C.
MedStar Union Memorial Hospital, Baltimore
Virginia Commonwealth University, Richmond
Wellstar Kennestone, Marietta
Piedmont Heart Institute, Atlanta
St. Vincent's Medical Center, Jacksonville
Grandview Medical Center, Birmingham
Cardiology Associates Research, LLC, Tupelo
Baptist Health Lexington, Lexington
Ohio State University, Columbus
Munson Medical Center, Traverse City
Marquette General Hospital, Marquette
Heart Hospital Baylor Plano (Baylor Research Institute), Plano
Christus Trinity Clinic Research, Tyler
Baylor Scott & White All Saints Medical Center, Fort Worth
Texas Cardiac Arrhythmia Research Foundation, Austin
Dignity Health Mercy Gilbert Medical Center, Chandler
Pacific Heart Institute / St. John's Health Center, Los Angeles
Monash Health, Melbourne
Lead Sponsor
Biosense Webster, Inc.
INDUSTRY
Coherex Medical
INDUSTRY